# OnCo record paper-tchekmedyian-lenvatinib-adenoid-cystic-jco-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-tchekmedyian-lenvatinib-adenoid-cystic-jco-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-tchekmedyian-lenvatinib-adenoid-cystic-jco-2019" ;
  schema:name "Phase 2 study of lenvatinib in progressive, recurrent or metastatic adenoid cystic carcinoma"@en ;
  schema:description "The multikinase inhibitor lenvatinib shrank tumours in about one in six patients with progressing adenoid cystic carcinoma and stabilised most of the rest, making it one of the few active drugs for this slow but relentless salivary cancer."@en ;
  schema:url <https://onco.cc/key-papers/paper-tchekmedyian-lenvatinib-adenoid-cystic-jco-2019/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.18.01859>, <https://pubmed.ncbi.nlm.nih.gov/30939095/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.18.01859> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Tchekmedyian V, Sherman EJ, Dunn L, et al." ;
  onco:cancers <https://onco.cc/cancers/adenoid-cystic-carcinoma/> ;
  onco:drugs <https://onco.cc/drugs/lenvatinib/> ;
  onco:journals <https://onco.cc/journals/jco/> .